myBiometry’s mission is to end asthma attacks. Asthma is an $82B problem in the US with 10M attacks annually and 16M uncontrolled patients. Asthma management fails 62% of the time because its reactive. Interventions only occur after symptoms or attacks. Our platform combines patented diagnostics, biomarkers, and digital health with machine learning and a care team to monitor patients at home. We prevent symptoms and attacks by delivering guideline-based coaching and education to patients at risk
